SGN-LIV1A
SGN-LIV1A Uses, Dosage, Side Effects, Food Interaction and all others data.
SGN-LIV1A is under investigation in clinical trial NCT01969643 (A Safety Study of SGN-LIV1A in Breast Cancer Patients).
Trade Name | SGN-LIV1A |
Generic | Ladiratuzumab vedotin |
Ladiratuzumab vedotin Other Names | Ladiratuzumab vedotin, SGN-LIV1A |
Type | |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here SGN-LIV1A